These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation. Seo SH, Jin HT, Park SH, Youn JI, Sung YC. Vaccine; 2009 Sep 25; 27(42):5906-12. PubMed ID: 19651174 [Abstract] [Full Text] [Related]
3. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells. Baghban Rahimi S, Mohebbi A, Vakilzadeh G, Biglari P, Razeghi Jahromi S, Mohebi SR, Shirian S, Gorji A, Ghaemi A. Arch Virol; 2018 Mar 25; 163(3):587-597. PubMed ID: 29149434 [Abstract] [Full Text] [Related]
4. DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity. Lin CT, Tsai YC, He L, Yeh CN, Chang TC, Soong YK, Monie A, Hung CF, Lai CH. Immunol Lett; 2007 Dec 15; 114(2):86-93. PubMed ID: 17976741 [Abstract] [Full Text] [Related]
7. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D. Diniz MO, Lasaro MO, Ertl HC, Ferreira LC. Clin Vaccine Immunol; 2010 Oct 15; 17(10):1576-83. PubMed ID: 20739505 [Abstract] [Full Text] [Related]
8. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice. Bahrami AA, Ghaemi A, Tabarraei A, Sajadian A, Gorji A, Soleimanjahi H. J Virol Methods; 2014 Sep 15; 206():12-8. PubMed ID: 24880067 [Abstract] [Full Text] [Related]
9. Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination. Lee SY, Huang Z, Kang TH, Soong RS, Knoff J, Axenfeld E, Wang C, Alvarez RD, Chen CS, Hung CF, Wu TC. J Mol Med (Berl); 2013 Oct 15; 91(10):1221-31. PubMed ID: 23715898 [Abstract] [Full Text] [Related]
10. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine]. Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct 15; 29(5):584-91. PubMed ID: 18051710 [Abstract] [Full Text] [Related]
16. Gene gun administration of therapeutic HPV DNA vaccination restores the efficacy of prolonged defrosted viral based vaccine. Lin CT, Yen CF, Shaw SW, Yen TC, Chen YJ, Soong YK, Lai CH. Vaccine; 2009 Dec 09; 27(52):7352-8. PubMed ID: 19781679 [Abstract] [Full Text] [Related]
17. GTL001 and bivalent CyaA-based therapeutic vaccine strategies against human papillomavirus and other tumor-associated antigens induce effector and memory T-cell responses that inhibit tumor growth. Esquerré M, Momot M, Goubier A, Gonindard C, Leung-Theung-Long S, Misseri Y, Bissery MC. Vaccine; 2017 Mar 13; 35(11):1509-1516. PubMed ID: 28196735 [Abstract] [Full Text] [Related]
19. Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses. Oosterhuis K, Aleyd E, Vrijland K, Schumacher TN, Haanen JB. Hum Gene Ther; 2012 Dec 13; 23(12):1301-12. PubMed ID: 22971245 [Abstract] [Full Text] [Related]